HAE – haemonetics corporation (US:NASDAQ)

News

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 [Yahoo! Finance]
Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp [Yahoo! Finance]
Haemonetics (NYSE:HAE) was given a new $81.00 price target on by analysts at Robert W. Baird.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com